Spots Global Cancer Trial Database for albumin paclitaxel
Every month we try and update this database with for albumin paclitaxel cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer | NCT04884906 | Locally Advance... | Camrelizumab radiotherapy Albumin Paclita... Cisplatin | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| A Study to Assess YH003 in Combination With Pebolizumab and Albumin Paclitaxel Injection in Subjects With Unresectable/Metastatic Mucosal Melanoma | NCT05420324 | Mucosal Melanom... | YH003 Pembrolizumab albumin paclita... | 18 Years - | Eucure (Beijing) Biopharma Co., Ltd | |
| Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma | NCT05996484 | Esophageal Carc... Neoadjuvant The... | Toripalimab Anlotinib hydro... Albumin paclita... Cisplatin | 18 Years - 75 Years | Nanfang Hospital, Southern Medical University | |
| Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma | NCT05515315 | Immunotherapy E... | Tislelizumab Albumin paclita... Nedaplatin radiotherapy | 18 Years - 70 Years | Fuzhou General Hospital | |
| Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer | NCT06391008 | Stereotactic Ra... | Stereotactic ra... Evoximab Pemetrexed Albumin Paclita... Carboplatin | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer | NCT04681911 | Breast Cancer | Inetetamab Pyrotinib Capecitabine Gemcitabine Vinorelbine Carboplatin Albumin paclita... Eribulin | 18 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC | NCT04768075 | Non-Small-Cell ... | Camrelizumab Placebo Cisplatin Carboplatin Pemetrexed Paclitaxel Albumin paclita... | 18 Years - 75 Years | Guangdong Association of Clinical Trials | |
| Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma | NCT05515315 | Immunotherapy E... | Tislelizumab Albumin paclita... Nedaplatin radiotherapy | 18 Years - 70 Years | Fuzhou General Hospital | |
| Combined Simvastatin and Albumin Paclitaxel in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy | NCT04698941 | Small Cell Lung... | Albumin Paclita... Simvastatin | 18 Years - 75 Years | Shanghai Pulmonary Hospital, Shanghai, China | |
| A Study for the Adjuvant Treatment of Breast Cancer | NCT05420467 | Breast Cancer | Docetaxel Carboplatin Trastuzumab Pertuzumab Nab paclitaxel Epirubicin Cyclophosphamid... Docetaxel Epirubicin Cyclophosphamid... Nab paclitaxel Cyclophosphamid... | 18 Years - | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II Trial | NCT05862168 | Oral Squamous C... | Tislelizumab Albumin paclita... Cisplatin 5-Fluorouracil | 18 Years - 75 Years | Zhejiang University | |
| Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer | NCT04152057 | Breast Cancer HER2 Positive Combination Che... | Pyrotinib Malea... Albumin Paclita... Trastuzumab | 18 Years - 70 Years | West China Hospital | |
| AK105 Plus Anlotinib Hydrochloride Combined With Albumin Paclitaxel as a First-line Therapy in Patients With Advanced Triple-negative Breast Cancer | NCT05244993 | Breast Neoplasm... | AK105 Anlotinib hydro... Albumin Paclita... | 18 Years - 75 Years | Liaoning Tumor Hospital & Institute | |
| Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II Trial | NCT05862168 | Oral Squamous C... | Tislelizumab Albumin paclita... Cisplatin 5-Fluorouracil | 18 Years - 75 Years | Zhejiang University | |
| A Study to Assess YH003 in Combination With Pebolizumab and Albumin Paclitaxel Injection in Subjects With Unresectable/Metastatic Mucosal Melanoma | NCT05420324 | Mucosal Melanom... | YH003 Pembrolizumab albumin paclita... | 18 Years - | Eucure (Beijing) Biopharma Co., Ltd | |
| Study of Chemotherapy and PD-1 Inhibitor Combination With Autologous CIK Cell Immunotherapy to Treat Lung Cancer | NCT04836728 | Non-small Cell ... First-line Trea... | CIK cell inject... Sintilimab Inje... Pemetrexed Albumin paclita... Carboplatin | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II Trial | NCT05862168 | Oral Squamous C... | Tislelizumab Albumin paclita... Cisplatin 5-Fluorouracil | 18 Years - 75 Years | Zhejiang University | |
| SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma | NCT04282070 | Nasopharyngeal ... | SHR-1701 Gemcitabine Cisplatin Albumin Paclita... | 18 Years - 75 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer | NCT04884906 | Locally Advance... | Camrelizumab radiotherapy Albumin Paclita... Cisplatin | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer | NCT04152057 | Breast Cancer HER2 Positive Combination Che... | Pyrotinib Malea... Albumin Paclita... Trastuzumab | 18 Years - 70 Years | West China Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
